Download PDF
Z Gastroenterol 2008; 46(7): 675-680
DOI: 10.1055/s-2008-1027409
Originalarbeit

© Georg Thieme Verlag KG Stuttgart · New York

Fallstricke bei der Zöliakiediagnostik

Pitfalls in Diagnosis of Celiac DiseaseJ. Henker1 , M. Laass1 , G. Baretton2 , R. Fischer2 , D. Aust2
  • 1Kinderklinik, Universitätsklinikum, Dresden
  • 2Institut für Pathologie, Universitätsklinikum, Dresden
Further Information

Publication History

Manuskript eingetroffen: 12.12.2007

Manuskript akzeptiert: 2.4.2008

Publication Date:
10 July 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Eckpfeiler in der Diagnostik der Zöliakie sind nach wie vor die serologische und histologische Diagnostik. Bei den serologischen Tests haben die IgA-Klasse-Endomysium-Antikörper und die Antikörper gegen Gewebstransglutaminase die höchste Sensitivität und Spezifität und sind als gleichwertig einzuschätzen. Ein IgA-Mangel im Serum ist immer auszuschließen. Antigliadin-Antikörper haben aufgrund ihres geringen positiven prädiktiven Wertes außer im jungen Kindesalter keine Bedeutung mehr bei der Diagnostik der Zöliakie. Die histologische Beurteilung von Dünndarmbiopsien sollte standardisiert nach den Marsh-Kriterien erfolgen. Diskrepante serologische und histologische Befunde erfordern eine sachkundige Bewertung durch einen Gastroenterologen und gegebenenfalls eine weiterführende Diagnostik.

Abstract

Both serology and histology remain cornerstones in the diagnosis of coeliac disease. IgA class antibodies against tissue transglutaminase and endomysium have the highest specificity and sensitivity in comparison with other serological tests. An IgA deficiency in serum must always be excluded. Antigliadin antibodies have, because of their low positive predictive value apart from in early childhood, no value as a diagnostic tool in coeliac disease. Intestinal biopsies should be evaluated according to the revised Marsh criteria. A discrepancy between serology and histology requires a competent evaluation by a gastroenterologist and, if necessary, further diagnostic procedures.

Schlüsselwörter

Sprue - Zöliakie - Serologie - Histologie - diskrepante Befunde

Key words

coeliac disease - serology - histology - discrepant findings

Literatur

  • 1 Holtmeier W, Henker J, Riecken E O. et al . Verlaufsformen und Definitionen der Zöliakie – Stellungnahme einer Expertengruppe der Deutschen Zöliakie-Gesellschaft.  Z Gastroenterol. 2005;  43 751-754
    Google Scholar
  • 2 Collin P, Kaukinen K, Vogelsang H. et al . Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study.  Eur J Gastroenterol Hepatol. 2005;  17 85-91
    Google Scholar
  • 3 Hill I D. What are the sensitivity and specificity of serological tests for celiac disease? Do sensitivity and specificity vary in different populations?.  Gastroenterology. 2005;  128 S25-S32
    Google Scholar
  • 4 Hill I D, Dirks M H, Liptak G S. et al . Guideline for the diagnosis and treatment ob celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.  J Pediatr Gastroenterol Nutr. 2005;  40 1-19
    Google Scholar
  • 5 Rostom A, Dube C, Cranney A. et al . The diagnostic accuracy of serologic tests for celiac disease: a systematic review.  Gastroenterology. 2005;  128 (Suppl 1) S38-46
    Google Scholar
  • 6 Pereira L F, Sapina A M, Arroyo J. et al . Prevalence of selective IgA deficiency in Spain: more than we thought.  Blood. 1997;  90 893
    Google Scholar
  • 7 Henker J, Lösel A, Conrad K. et al . Prävalenz der asymptomatischen Zöliakie bei Kindern und Erwachsenen in der Region Dresden.  Dtsch Med Wochenschr. 2002;  127 1511-1515
    Google Scholar
  • 8 Laass M W, Koch T, Lösel A. et al . Longitudinal follow-up examination of antigliadin antibody positive children and adults.  Eur J Gastroenterol Hepatol. 2006;  18 503-506
    Google Scholar
  • 9 Ravelli A, Bolognini S, Gambarotti M. et al . Variability of Histologic lesions in relation to biopsy site in gluten-sensitive enteropathy.  Am J Gastroenterol. 2005;  100 177-185
    Google Scholar
  • 10 Vogelsang H, Hanel S, Steiner B. et al . Diagnostic duodenal bulb biopsy in celiac disease.  Endoscopy. 2001;  33 336-340
    Google Scholar
  • 11 Marsh M N. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’).  Gastroenterology. 1992;  102 330-354
    Google Scholar
  • 12 Marsh M N, Crowe P T. Morphology of the mucosal lesion in gluten sensitivity.  Baillieres Clin Gastroenterol. 1995;  9 273-293
    Google Scholar
  • 13 Ferguson A, Murray D. Quantitation of intraepithelial lymphocytes in human jejunum.  Gut. 1971;  12 988-994
    Google Scholar
  • 14 Chang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa.  APMIS. 2005;  113 385-399
    Google Scholar
  • 15 Hayat M, Cairns A, Dixon M F. et al . Quantitation of intraepithelial lymphocytes in human duodenum: what is normal?.  J Clin Pathol. 2002;  55 393-395
    Google Scholar
  • 16 Hayday A, Theodoridis E, Ramsburg E. et al . Intraepithelial lymphocytes: exploring the third way in immunology.  Nat Immunol. 2001;  2 997-1003
    Google Scholar
  • 17 Mahadeva S, Wyatt J I, Howdle P D. Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant?.  J Clin Pathol. 2002;  55 424-428
    Google Scholar
  • 18 Marsh M N, Loft D E, Garner V G. et al . Time/Dose responses of coeliac mucosae to graded oral challenges with Frazer’s fraction III of gliadin.  Eur J Gastroenterol Hepatol. 1992;  4 667-673
    Google Scholar
  • 19 Veress B, Franzén L, Bodin L. et al . Duodenal intraepithelial lymphocyte-count revisited.  Scand J Gastroenterol. 2004;  39 138-144
    Google Scholar
  • 20 Fry L, Seah P P, McMinn R M. et al . Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy.  Br Med J. 1972;  3 371-374
    Google Scholar
  • 21 Kuitunen P, Kosnai I, Savilahti E. Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphozytes.  J Pediatr Gastroenterol Nutr. 1982;  1 525-531
    Google Scholar
  • 22 Thijs W J, Baarlen van J, Mulder C JJ. et al . Small bowel intra-epithelial lymphocytosis and normal villous architecture (Marsh I): gluten sensitive enteropathy?.  Gastroenterology. 1999;  116 A897
    Google Scholar
  • 23 UEGW 2001 Working Group on Coeliac Disease . When is a coeliac a coeliac?.  Eur J Gastroenterol Hepatol. 2001;  13 1123-1128
    Google Scholar
  • 24 Dickson B C, Streutker C J, Chetty R. Coeliac disease: an update for pathologists.  J Clin Pathol. 2006;  59 1008-1016
    Google Scholar
  • 25 Lundin K EA. Commentary:Transient coeliac disease back on stage again?.  (Editorial) Scand J Gastroenterol. 2005;  40 1137-1139
    Google Scholar
  • 26 Freeman H J. Adult celiac disease and the severe “flat” small bowel biopsy lesion.  Dig Dis Sciences. 2004;  49 535-545
    Google Scholar
  • 27 Craig D, Robins G, Howdle P D. Advances in celiac disease.  Curr Opin Gastroenterol. 2007;  23 142-148
    Google Scholar
  • 28 Paparo F, Petrone E, Tosco A. et al . Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturelly normal small intestinal mucosa.  Am J Gastroenterol. 2005;  100 2294-2298
    Google Scholar
  • 29 Dickey W, Hughes D F, McMillan S A. Reliance on serum endomysial antibody testing underestimates the true prevalence of celiac disease by one fifth.  Scand J Gastroenterol. 2000;  35 181-183
    Google Scholar
  • 30 Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics and effect of a gluten-free diet.  Am J Gastroenterol. 2006;  101 2356-2359
    Google Scholar
  • 31 Cataldo F, Marino V, Ventura A. et al . Prevalence and clinical features of selective immunoglobulin A deficiency in celiac disease: an Italian multicenter study.  Gut. 1998;  42 362-365
    Google Scholar
  • 32 Cataldo F, Lio D, Marino V. et al . IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency.  Gut. 2000;  47 366-369
    Google Scholar
  • 33 Dahele A, Kingstone K, Bode J. et al . Antiendomysial antibody negative celiac disease: does additional serological testing help?.  Dig Dis Sciences. 2001;  46 214-221
    Google Scholar
  • 34 Dahele A V, Aldhous M C, Humphreys K. et al . Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases.  Q J Med. 2001;  94 195-205
    Google Scholar
  • 35 Dickey W, Hughes D F, McMillan S A. Patients with serum IgA endomysial antibodies and intact duodenal villi: Clinical characteristics and management options.  Scand J Gastroenterol. 2005;  40 1240-1243
    Google Scholar
  • 36 Rostami K, Kerckhaert J, Tiemessen R. et al . Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice.  Am J Gastroenterol. 1999;  94 888-894
    Google Scholar
  • 37 Ashabani A, Errabtea H, Shapan A. et al . Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies.  J Pediatr Gastroenterol Nutr. 2001;  33 276-282
    Google Scholar
  • 38 Prasad S, Thomas P, Nicholas D S. et al . Adult endomysial antbody-negatve coeliac disease and cigarette smoking.  Eur J Gastroenterol Hepatol. 2001;  13 667-671
    Google Scholar
  • 39 Hopper A D, Cross S S, Hurlstone D P. et al . Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool.  Br Med J. online first 23.3.2007;  DOI: 0.1136 /bmj. 39 133.668681.BE
    Google Scholar
  • 40 Abrams J A, Diamond B, Rotterdam H. et al . Seronegative celiac disease: Increased prevalence with lesser degrees of villous atrophy.  Dig Dis Sciences. 2004;  49 546-550
    Google Scholar
  • 41 Salmi T T, Collin P, Korponay-Szabo I R. et al . Endomysial antibody-negative coeliac disease:clinical characteristics and intestinal autoantibody deposits.  Gut. 2006;  55 1746-1753
    Google Scholar
  • 42 Picarelli A, Di Tola M, Sabbatella L. et al . Identification of a new coeliac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency.  J Intern Medicine. 2001;  249 181-188
    Google Scholar
  • 43 American Gastroenterological Association medical position statement: Celiac Sprue.  Gastroenterology. 2001;  120 1522-1525
    Google Scholar
  • 44 Rostami K, Kerckhaert J P, Tiemessen R. et al . The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate.  Eur J Gastroenterol Hepatol. 1999;  11 439-442
    Google Scholar
  • 45 Sategna-Guidetti C, Pulitano R, Grosso S. et al . Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue.  J Clin Gastroenterol. 1993;  17 123-127
    Google Scholar
  • 46 Shamir R, Lerner A, Shinar E. et al . The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors.  Am J Gastroenterol. 2002;  97 2589-2594
    Google Scholar
  • 47 Dickey W, McMillan S A, Hughes D F. Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease.  Scand J Gastroenterol. 2001;  36 511-514
    Google Scholar
  • 48 Sugai E, Vazquez H, Nachman F. et al . Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease.  Clin Gastroenterol Hepatol. 2006;  4 1112-1117
    Google Scholar
  • 49 Mothes T. Deamidated gliadin peptides as targets for celiac disease-specific antibodies.  Advances in clinical chemistry. 2007;  44 35-63
    Google Scholar

Prof. Dr. Jobst Henker

Kinderklinik, Universitätsklinikum

Fetscherstraße 74

01307 Dresden

Phone: ++ 49/3 51/4 58 34 49

Fax: ++ 49/3 51/4 58 53 58

Email: jobst.henker@uniklinikum-dresden.de

      >